# FDA 483 - Hangzhou Facecare Cosmetics Co., Ltd. - June 19, 2017

Source: https://www.globalkeysolutions.net/records/483/hangzhou-facecare-cosmetics-co-ltd/f02694e2-fe70-48b7-a0f5-4197ea0c6c6d

> FDA 483 for Hangzhou Facecare Cosmetics Co., Ltd. on June 19, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hangzhou Facecare Cosmetics Co., Ltd.
- Inspection Date: 2017-06-19
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
- Summary: An FDA inspection of Hangzhou Facecare Cosmetics Co. Ltd in Hangzhou, China, revealed 12 significant deficiencies in their drug manufacturing operations. The firm failed to conduct essential testing for active ingredients, establish expiration dates, perform stability studies, or validate critical processes and equipment. These widespread issues indicate a severe lack of adherence to Good Manufacturing Practices.

## Related Documents

- [WARNING_LETTER - 2017-06-22](https://www.globalkeysolutions.net/records/warning_letter/hangzhou-facecare-cosmetics-co-ltd/8eecae36-b8c9-465d-810b-c1b4a8dd291b)
- [483 - 2019-04-05](https://www.globalkeysolutions.net/records/483/hangzhou-facecare-cosmetics-co-ltd/9fc0aee4-a407-4e7b-b89d-d170c0537770)

## Related Officers

- [Uttaniti Limchumroon](https://www.globalkeysolutions.net/people/uttaniti-limchumroon/ce890cbf-2f5c-498f-917c-0edf8b10d356)

Company: https://www.globalkeysolutions.net/companies/hangzhou-facecare-cosmetics-co-ltd/caeaa010-09c9-4b80-99ae-9b9b1f674a60

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd